Multi-tissue integrated Mendelian randomization method identifies disease risk genes
Briefings in Bioinformatics · 03.07.2026 · 27 (4)
DOI: 10.1093/bib/bbag414 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 28.07.2026. Verfasst von Yu Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, No. 639 Longmian Ave, Jiangning District, Nanjing 21110…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Central Universities of China Pharmaceutical University, National Natural Science Foundation of China, National Science Foundation for Young Scientists of China.
Abstract (Originalsprache)
Mendelian randomization (MR) leverages genetic variants as instrumental variables to infer causal relationships between molecular traits and diseases, however, identifying the specific causal genes underlying disease risk remains challenging. Here, we present MULTI (Multi-tissue Unified Likelihood-based Transcriptomic Integration), a Bayesian MR framework that integrates genetic information across tissues to improve the accuracy of causal inference. MULTI yields reliable estimates even when the number of instruments in a single tissue is limited, and further increases statistical power by adaptively integrating information from similar tissues without inflating type I error rates. Extensive simulations confirm its robustness under diverse genetic architectures, and applications to real datasets demonstrate its capacity to reveal tissue-specific causal mechanisms and coordinated cross-tissue regulation. MULTI offers a practical and extensible framework for elucidating the molecular architecture of complex human diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, No. 639 Longmian Ave, Jiangning District, Nanjing 211100, Jiangsu, China.
ORCID-Profile: Xinjia Ruan, Tiantian Liu, Fangrong Yan
Förderung
- Fundamental Research Funds for the Central Universities of China Pharmaceutical University
- National Natural Science Foundation of China
- National Science Foundation for Young Scientists of China
- 2024 National Key Research on Multi-Target Natural Drugs
- Key Laboratory of Scientific and Engineering Computing (Ministry of Education)
- Shanghai Frontiers Science Center of Modern Analysis
Zitieren
APA
Cheng, Y., Liu, S., Ruan, X., Li, Z., Jiang, L., Liu, T., & Yan, F. (2026). Multi-tissue integrated Mendelian randomization method identifies disease risk genes. Briefings in Bioinformatics, 27(4). https://doi.org/10.1093/bib/bbag414
Vancouver
Cheng Y, Liu S, Ruan X, Li Z, Jiang L, Liu T, et al. Multi-tissue integrated Mendelian randomization method identifies disease risk genes. Briefings in Bioinformatics. 2026;27(4). doi:10.1093/bib/bbag414
BibTeX
@article{Cheng2026,
author = {Cheng, Yu and Liu, Shuhan and Ruan, Xinjia and Li, Zhonghua and Jiang, Liyun and Liu, Tiantian and Yan, Fangrong},
title = {Multi-tissue integrated Mendelian randomization method identifies disease risk genes},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {4},
doi = {10.1093/bib/bbag414}
}
EUVIMED